Skip to main content
Erschienen in: Pediatric Cardiology 1/2021

09.10.2020 | Original Article

Cardiac Phenotype–Genotype Associations in DMD/BMD: A Meta-Analysis and Systematic Review

verfasst von: Huan Zhou, Manli Fu, Bing Mao, Li Yuan

Erschienen in: Pediatric Cardiology | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Abstract

Cardiac involvement of Duchenne and Becker muscular dystrophies (DMD/BMD) is the most common cause of fatal outcomes. It is still unclear whether some DMD/BMD gene mutations might be predictive of cardiac involvement. In this study, we provide a comprehensive overview on genotypes of cardiac disease in DMD/BMD. We systematically searched the PubMed/Medline, EMBASE and Cochrane electronic databases. Search results were filtered to include only human studies, English language and all dates up to August 2019. We summarized and extensively reviewed all studies that passed the selection criteria and performed a meta-analysis on key genotype parameters of cardiac disease in DMD/BMD. Of 3450 articles scanned, we included 18 studies from 9 regions in the meta-analysis. The pooled studies included 2661 DMD/BMD patients and 1324 DMD/BMD patients with cardiac disease. The most common mutation type was exon deletion, with a pooled frequency of 90% (P < 0.01). In DMD/BMD patients with cardiac dysfunction, a higher frequency of involvement of exons 45 and 46 was found in DMD/BMD patients with cardiac dysfunction. This might be predictive of cardiac involvement in patients with DMD/BMD.
Literatur
1.
Zurück zum Zitat Muntoni F, Torelli S, Ferlini A (2003) Dystrophin and mutations: one gene, several proteins, multiple phenotypes. Lancet Neurol 2:731PubMed Muntoni F, Torelli S, Ferlini A (2003) Dystrophin and mutations: one gene, several proteins, multiple phenotypes. Lancet Neurol 2:731PubMed
2.
Zurück zum Zitat Emery AE (1991) Population frequencies of inherited neuromuscular diseases–a world survey. Neuromuscul Disord Nmd 1:19PubMed Emery AE (1991) Population frequencies of inherited neuromuscular diseases–a world survey. Neuromuscul Disord Nmd 1:19PubMed
3.
Zurück zum Zitat Kohler M, Clarenbach CF, Bahler C, Brack T, Russi EW, Bloch KE (2009) Disability and survival in Duchenne muscular dystrophy. J Neurol Neurosurg Psychiatry 80:320PubMed Kohler M, Clarenbach CF, Bahler C, Brack T, Russi EW, Bloch KE (2009) Disability and survival in Duchenne muscular dystrophy. J Neurol Neurosurg Psychiatry 80:320PubMed
4.
Zurück zum Zitat Ishikawa Y, Miura T, Ishikawa Y, Aoyagi T, Ogata H, Hamada S, Minami R (2011) Duchenne muscular dystrophy: Survival by cardio-respiratory interventions. Neuromuscul Disorders Nmd 21:47 Ishikawa Y, Miura T, Ishikawa Y, Aoyagi T, Ogata H, Hamada S, Minami R (2011) Duchenne muscular dystrophy: Survival by cardio-respiratory interventions. Neuromuscul Disorders Nmd 21:47
5.
Zurück zum Zitat Bushby K, Muntoni F, Bourke JP (2003) 107th ENMC international workshop: the management of cardiac involvement in muscular dystrophy and myotonic dystrophy. 7th-9th June 2002 Naarden, the Netherlands. Neuromuscul Disord 2003(13):166 Bushby K, Muntoni F, Bourke JP (2003) 107th ENMC international workshop: the management of cardiac involvement in muscular dystrophy and myotonic dystrophy. 7th-9th June 2002 Naarden, the Netherlands. Neuromuscul Disord 2003(13):166
6.
Zurück zum Zitat Mcnally EM, Kaltman JR, Woodrow Benson D, Canter CE, Cripe LH, Duan D, Finder JD, Hoffman EP, Judge DP, Kertesz N (2015) Contemporary cardiac issues in Duchenne muscular dystrophy. Circulation 131:1590PubMedPubMedCentral Mcnally EM, Kaltman JR, Woodrow Benson D, Canter CE, Cripe LH, Duan D, Finder JD, Hoffman EP, Judge DP, Kertesz N (2015) Contemporary cardiac issues in Duchenne muscular dystrophy. Circulation 131:1590PubMedPubMedCentral
7.
Zurück zum Zitat Birnkrant DJ, Ararat E, Mhanna MJ (2016) Cardiac phenotype determines survival in Duchenne muscular dystrophy. Pediatr Pulmonol 51:70PubMed Birnkrant DJ, Ararat E, Mhanna MJ (2016) Cardiac phenotype determines survival in Duchenne muscular dystrophy. Pediatr Pulmonol 51:70PubMed
8.
Zurück zum Zitat Kamdar F, Garry DJ (2016) Dystrophin-deficient cardiomyopathy. J Am Coll Cardiol 67:2533PubMed Kamdar F, Garry DJ (2016) Dystrophin-deficient cardiomyopathy. J Am Coll Cardiol 67:2533PubMed
9.
Zurück zum Zitat Cox GF, Kunkel LM (1997) Dystrophies and heart disease. Curr Opin Cardiol 12:329PubMed Cox GF, Kunkel LM (1997) Dystrophies and heart disease. Curr Opin Cardiol 12:329PubMed
10.
Zurück zum Zitat Melacini P, Fanin M, Danieli GA, Villanova C, Martinello F, Miorin M, Freda MP, Miorelli M, Mostacciuolo ML, Fasoli G, Angelini C, Dalla VS (1996) Myocardial involvement is very frequent among patients affected with subclinical Becker's muscular dystrophy. Circulation 94:3168PubMed Melacini P, Fanin M, Danieli GA, Villanova C, Martinello F, Miorin M, Freda MP, Miorelli M, Mostacciuolo ML, Fasoli G, Angelini C, Dalla VS (1996) Myocardial involvement is very frequent among patients affected with subclinical Becker's muscular dystrophy. Circulation 94:3168PubMed
11.
Zurück zum Zitat Burch M, Siddiqi SA, Celermajer DS, Scott C, Bull C, Deanfield JE (1994) Dilated cardiomyopathy in children: determinants of outcome. Br Heart J 72:246PubMedPubMedCentral Burch M, Siddiqi SA, Celermajer DS, Scott C, Bull C, Deanfield JE (1994) Dilated cardiomyopathy in children: determinants of outcome. Br Heart J 72:246PubMedPubMedCentral
12.
Zurück zum Zitat Berko BA, Swift M (1987) X-linked dilated cardiomyopathy. New Engl J Med 330:368 Berko BA, Swift M (1987) X-linked dilated cardiomyopathy. New Engl J Med 330:368
13.
Zurück zum Zitat Kaspar RW, Allen HD, Ray WC, Alvarez CE, Kissel JT, Pestronk A, Weiss RB, Flanigan KM, Mendell JR, Montanaro F (2009) Analysis of dystrophin deletion mutations predicts age of cardiomyopathy onset in Becker muscular dystrophy. Circ Cardiovasc Genet 2:544PubMedPubMedCentral Kaspar RW, Allen HD, Ray WC, Alvarez CE, Kissel JT, Pestronk A, Weiss RB, Flanigan KM, Mendell JR, Montanaro F (2009) Analysis of dystrophin deletion mutations predicts age of cardiomyopathy onset in Becker muscular dystrophy. Circ Cardiovasc Genet 2:544PubMedPubMedCentral
14.
Zurück zum Zitat Nigro G, Comi LI, Politano L, Bain RJI (1990) The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy. Int J Cardiol 26:271PubMed Nigro G, Comi LI, Politano L, Bain RJI (1990) The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy. Int J Cardiol 26:271PubMed
15.
Zurück zum Zitat Raman SV, Hor KN, Mazur W, Halnon NJ, Kissel JT, He X, Tran T, Smart S, Mccarthy B, Taylor MD (2015) Eplerenone for early cardiomyopathy in Duchenne muscular dystrophy: A randomised, double-blind, placebo-controlled trial. Lancet Neurol 14:153PubMed Raman SV, Hor KN, Mazur W, Halnon NJ, Kissel JT, He X, Tran T, Smart S, Mccarthy B, Taylor MD (2015) Eplerenone for early cardiomyopathy in Duchenne muscular dystrophy: A randomised, double-blind, placebo-controlled trial. Lancet Neurol 14:153PubMed
16.
Zurück zum Zitat Allen HD, Flanigan KM, Thrush PT, Dvorchik I, Yin H, Canter C, Connolly AM, Parrish M, Mcdonald CM, Braunlin E (2013) A randomized, double-blind trial of lisinopril and losartan for the treatment of cardiomyopathy in Duchenne muscular dystrophy. PLoS Currents 5:2c Allen HD, Flanigan KM, Thrush PT, Dvorchik I, Yin H, Canter C, Connolly AM, Parrish M, Mcdonald CM, Braunlin E (2013) A randomized, double-blind trial of lisinopril and losartan for the treatment of cardiomyopathy in Duchenne muscular dystrophy. PLoS Currents 5:2c
17.
Zurück zum Zitat Viollet L, Thrush PT, Flanigan KM, Mendell JR, Allen HD (2012) Effects of angiotensin-converting enzyme inhibitors and/or beta blockers on the cardiomyopathy in Duchenne muscular dystrophy. Am J Cardiol 110:98PubMed Viollet L, Thrush PT, Flanigan KM, Mendell JR, Allen HD (2012) Effects of angiotensin-converting enzyme inhibitors and/or beta blockers on the cardiomyopathy in Duchenne muscular dystrophy. Am J Cardiol 110:98PubMed
18.
Zurück zum Zitat Kwon SW, Lee BK, Hong BK, Kim JY, Choi EY, Ji MS, Rhee JH, Park YM, Ma DW, Chung H (2013) Prognostic significance of elevated lipoprotein(a) in coronary artery revascularization patients. Int J Cardiol 167:1990PubMed Kwon SW, Lee BK, Hong BK, Kim JY, Choi EY, Ji MS, Rhee JH, Park YM, Ma DW, Chung H (2013) Prognostic significance of elevated lipoprotein(a) in coronary artery revascularization patients. Int J Cardiol 167:1990PubMed
19.
Zurück zum Zitat Rhodes J, Margossian RB, Colan S, Jenkins K, Geva T, Powell A (2008) Safety and efficacy of carvedilol therapy for patients with dilated cardiomyopathy secondary to muscular dystrophy. Pediatr Cardiol 29:343PubMed Rhodes J, Margossian RB, Colan S, Jenkins K, Geva T, Powell A (2008) Safety and efficacy of carvedilol therapy for patients with dilated cardiomyopathy secondary to muscular dystrophy. Pediatr Cardiol 29:343PubMed
20.
Zurück zum Zitat Ramaciotti C, Heistein LC, Coursey M, Lemler MS, Eapen RS, Iannaccone ST, Scott WA (2007) Left ventricular function and response to enalapril in patients with Duchenne muscular dystrophy during the second decade of life. Am J Cardiol 98:825 Ramaciotti C, Heistein LC, Coursey M, Lemler MS, Eapen RS, Iannaccone ST, Scott WA (2007) Left ventricular function and response to enalapril in patients with Duchenne muscular dystrophy during the second decade of life. Am J Cardiol 98:825
21.
Zurück zum Zitat Markham LW, Kinnett K, Wong BL, Woodrow BD, Cripe LH (2008) Corticosteroid treatment retards development of ventricular dysfunction in Duchenne muscular dystrophy. Neuromuscul Disord 18:365PubMed Markham LW, Kinnett K, Wong BL, Woodrow BD, Cripe LH (2008) Corticosteroid treatment retards development of ventricular dysfunction in Duchenne muscular dystrophy. Neuromuscul Disord 18:365PubMed
22.
Zurück zum Zitat Markham LW, Spicer RL, Khoury PR, Wong BL, Mathews KD, Cripe LH (2005) Steroid therapy and cardiac function in Duchenne muscular dystrophy. Pediatr Cardiol 26:768PubMed Markham LW, Spicer RL, Khoury PR, Wong BL, Mathews KD, Cripe LH (2005) Steroid therapy and cardiac function in Duchenne muscular dystrophy. Pediatr Cardiol 26:768PubMed
23.
Zurück zum Zitat Barber BJ, Andrews JG, Zhenqiang L, West NA, John Meaney F, Price ET, Ashley G, Sheehan DW, Shree P, Michele Y (2013) Oral corticosteroids and onset of cardiomyopathy in Duchenne muscular dystrophy. J Pediatr-US 163:1080 Barber BJ, Andrews JG, Zhenqiang L, West NA, John Meaney F, Price ET, Ashley G, Sheehan DW, Shree P, Michele Y (2013) Oral corticosteroids and onset of cardiomyopathy in Duchenne muscular dystrophy. J Pediatr-US 163:1080
24.
Zurück zum Zitat Houde S, Filiatrault M, Fournier A, Dubé J, D'Arcy S, Bérubé D, Brousseau Y, Lapierre G, Vanasse M (2008) Deflazacort use in Duchenne muscular dystrophy: an 8-year follow-up. Pediatr Neurol 38:200PubMed Houde S, Filiatrault M, Fournier A, Dubé J, D'Arcy S, Bérubé D, Brousseau Y, Lapierre G, Vanasse M (2008) Deflazacort use in Duchenne muscular dystrophy: an 8-year follow-up. Pediatr Neurol 38:200PubMed
25.
Zurück zum Zitat Schram G, Fournier A, Leduc H, Dahdah N, Therien J, Vanasse M, Khairy P (2013) All-cause mortality and cardiovascular outcomes with prophylactic steroid therapy in Duchenne muscular dystrophy. J Am Coll Cardiol 61:948PubMed Schram G, Fournier A, Leduc H, Dahdah N, Therien J, Vanasse M, Khairy P (2013) All-cause mortality and cardiovascular outcomes with prophylactic steroid therapy in Duchenne muscular dystrophy. J Am Coll Cardiol 61:948PubMed
26.
Zurück zum Zitat Ogata H, Ishikawa Y, Ishikawa Y, Minami R (2009) Beneficial effects of beta-blockers and angiotensin-converting enzyme inhibitors in Duchenne muscular dystrophy. J Cardiol 53:316 Ogata H, Ishikawa Y, Ishikawa Y, Minami R (2009) Beneficial effects of beta-blockers and angiotensin-converting enzyme inhibitors in Duchenne muscular dystrophy. J Cardiol 53:316
27.
Zurück zum Zitat Herrera Enríquez MC (2007) Perindopril preventive treatment on mortality in Duchenne muscular dystrophy: 10 years' follow-up. Am Heart J 154:596 Herrera Enríquez MC (2007) Perindopril preventive treatment on mortality in Duchenne muscular dystrophy: 10 years' follow-up. Am Heart J 154:596
28.
Zurück zum Zitat Jefferies JL, Eidem BW, Belmont JW, Craigen WJ, Ware SM, Fernbach SD, Neish SR, Smith EO, Towbin JA (2005) Genetic predictors and remodeling of dilated cardiomyopathy in muscular dystrophy. Circulation 112:2799PubMed Jefferies JL, Eidem BW, Belmont JW, Craigen WJ, Ware SM, Fernbach SD, Neish SR, Smith EO, Towbin JA (2005) Genetic predictors and remodeling of dilated cardiomyopathy in muscular dystrophy. Circulation 112:2799PubMed
29.
Zurück zum Zitat Ashwath ML, Jacobs IB, Crowe CA, Ashwath RC, Super DM, Bahler RC (2014) Left ventricular dysfunction in Duchenne muscular dystrophy and genotype. Am J Cardiol 114:284PubMedPubMedCentral Ashwath ML, Jacobs IB, Crowe CA, Ashwath RC, Super DM, Bahler RC (2014) Left ventricular dysfunction in Duchenne muscular dystrophy and genotype. Am J Cardiol 114:284PubMedPubMedCentral
30.
Zurück zum Zitat Moher D, Liberati A, Tetzlaff J, Altman D (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Rev Española De Nutr Hum Y Dietética 18:123 Moher D, Liberati A, Tetzlaff J, Altman D (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Rev Española De Nutr Hum Y Dietética 18:123
31.
Zurück zum Zitat Cirino RHD, Scola RH, Ducci RDP, Wermelinger ACC, Kay CSK, Lorenzoni PJ, Werneck LC, Carmes ER, Da CCLP (2018) Predictors of early left ventricular systolic dysfunction in Duchenne muscular dystrophy patients. Muscle Nerve 58:84 Cirino RHD, Scola RH, Ducci RDP, Wermelinger ACC, Kay CSK, Lorenzoni PJ, Werneck LC, Carmes ER, Da CCLP (2018) Predictors of early left ventricular systolic dysfunction in Duchenne muscular dystrophy patients. Muscle Nerve 58:84
32.
Zurück zum Zitat Gambetta K, Wittlieb-Weber C, Bock M, Villa C, Johnson J, Lal A, Schumacher K, Law S, Deshpande S, West S, Friedland-Little J, Lytrivi I, Butts R, Cunningham C, Knecht KR, McCullough M (2018) Impact of genotype on boys with Duchenne muscular dystrophy. J Heart Lung Transpl 37:S122 Gambetta K, Wittlieb-Weber C, Bock M, Villa C, Johnson J, Lal A, Schumacher K, Law S, Deshpande S, West S, Friedland-Little J, Lytrivi I, Butts R, Cunningham C, Knecht KR, McCullough M (2018) Impact of genotype on boys with Duchenne muscular dystrophy. J Heart Lung Transpl 37:S122
33.
Zurück zum Zitat Martins E, Silva-Cardoso J, Silveira F, Nadais G, Rocha GF (2005) Left ventricular function in adults with muscular dystrophies: genotype-phenotype correlations. Rev Port Cardiol 24:23PubMed Martins E, Silva-Cardoso J, Silveira F, Nadais G, Rocha GF (2005) Left ventricular function in adults with muscular dystrophies: genotype-phenotype correlations. Rev Port Cardiol 24:23PubMed
34.
Zurück zum Zitat Nakamura K, Goto K, Ishikawa T, Shimazaki R, Matsubara E (2017) Genotype of early death due to cardiac failure in Duchenne muscular dystrophy. J Neurol Sci 381:823 Nakamura K, Goto K, Ishikawa T, Shimazaki R, Matsubara E (2017) Genotype of early death due to cardiac failure in Duchenne muscular dystrophy. J Neurol Sci 381:823
35.
Zurück zum Zitat Del GD, Yang Y, Boggs BA, Schmitt ES, Lee JA, Sahoo T, Pham HT, Wiszniewska J, Chinault AC, Beaudet AL, Eng CM (2008) Molecular diagnosis of Duchenne/Becker muscular dystrophy: enhanced detection of dystrophin gene rearrangements by oligonucleotide array-comparative genomic hybridization. Hum Mutat 29:1100 Del GD, Yang Y, Boggs BA, Schmitt ES, Lee JA, Sahoo T, Pham HT, Wiszniewska J, Chinault AC, Beaudet AL, Eng CM (2008) Molecular diagnosis of Duchenne/Becker muscular dystrophy: enhanced detection of dystrophin gene rearrangements by oligonucleotide array-comparative genomic hybridization. Hum Mutat 29:1100
36.
Zurück zum Zitat Aartsma-Rus A, Ginjaar IB, Bushby K (2016) The importance of genetic diagnosis for Duchenne muscular dystrophy. J Med Genet 53:145PubMedPubMedCentral Aartsma-Rus A, Ginjaar IB, Bushby K (2016) The importance of genetic diagnosis for Duchenne muscular dystrophy. J Med Genet 53:145PubMedPubMedCentral
37.
Zurück zum Zitat Findlay AR, Wein N, Kaminoh Y, Taylor LE, Dunn DM, Mendell JR, King WM, Pestronk A, Florence JM, Mathews KD, Finkel RS, Swoboda KJ, Howard MT, Day JW, McDonald C, Nicolas A, Le Rumeur E, Weiss RB, Flanigan KM (2015) Clinical phenotypes as predictors of the outcome of skipping around DMD exon 45. Ann Neurol 77:668PubMedPubMedCentral Findlay AR, Wein N, Kaminoh Y, Taylor LE, Dunn DM, Mendell JR, King WM, Pestronk A, Florence JM, Mathews KD, Finkel RS, Swoboda KJ, Howard MT, Day JW, McDonald C, Nicolas A, Le Rumeur E, Weiss RB, Flanigan KM (2015) Clinical phenotypes as predictors of the outcome of skipping around DMD exon 45. Ann Neurol 77:668PubMedPubMedCentral
38.
Zurück zum Zitat Duboc D, Meune C, Pierre B, Wahbi K, Eymard B, Toutain A, Berard C, Vaksmann G, Weber S, Bécane H (2007) Perindopril preventive treatment on mortality in Duchenne muscular dystrophy: 10 years' follow-up. Am Heart J 154:596PubMed Duboc D, Meune C, Pierre B, Wahbi K, Eymard B, Toutain A, Berard C, Vaksmann G, Weber S, Bécane H (2007) Perindopril preventive treatment on mortality in Duchenne muscular dystrophy: 10 years' follow-up. Am Heart J 154:596PubMed
39.
Zurück zum Zitat Matsumura T, Tamura T, Kuru S, Kikuchi Y, Kawai M (2010) Carvedilol can prevent cardiac events in Duchenne muscular dystrophy. Intern Med 49:1357PubMed Matsumura T, Tamura T, Kuru S, Kikuchi Y, Kawai M (2010) Carvedilol can prevent cardiac events in Duchenne muscular dystrophy. Intern Med 49:1357PubMed
40.
Zurück zum Zitat Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L, Kaul A, Kinnett K, McDonald C, Pandya S, Poysky J, Shapiro F, Tomezsko J, Constantin C (2010) Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care. Lancet Neurol 9:177PubMed Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L, Kaul A, Kinnett K, McDonald C, Pandya S, Poysky J, Shapiro F, Tomezsko J, Constantin C (2010) Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care. Lancet Neurol 9:177PubMed
41.
Zurück zum Zitat Kolski H, Spurney C, Morgenroth PL, Shimizu R, Clemens RP (2014) Cooperative international neuromuscular research group Duchenne natural history study demonstrates insufficient diagnosis and treatment of cardiomyopathy in Duchenne muscular dystrophy. Muscle Nerve 50(2):250–256PubMedPubMedCentral Kolski H, Spurney C, Morgenroth PL, Shimizu R, Clemens RP (2014) Cooperative international neuromuscular research group Duchenne natural history study demonstrates insufficient diagnosis and treatment of cardiomyopathy in Duchenne muscular dystrophy. Muscle Nerve 50(2):250–256PubMedPubMedCentral
42.
Zurück zum Zitat Nigro G, Politano L, Nigro V, Petretta VR, Comi LI (1994) Mutation of dystrophin gene and cardiomyopathy. Neuromuscul Disord 4:371PubMed Nigro G, Politano L, Nigro V, Petretta VR, Comi LI (1994) Mutation of dystrophin gene and cardiomyopathy. Neuromuscul Disord 4:371PubMed
43.
Zurück zum Zitat Freund AA, Scola RH, Arndt RC, Lorenzoni PJ, Kay CK, Werneck LC (2007) Duchenne and Becker muscular dystrophy: a molecular and immunohistochemical approach. Arq Neuropsiquiatr 65:73PubMed Freund AA, Scola RH, Arndt RC, Lorenzoni PJ, Kay CK, Werneck LC (2007) Duchenne and Becker muscular dystrophy: a molecular and immunohistochemical approach. Arq Neuropsiquiatr 65:73PubMed
44.
Zurück zum Zitat Bostick B, Yue Y, Long C, Marschalk N, Fine DM, Chen J, Duan D (2009) Cardiac expression of a mini-dystrophin that normalizes skeletal muscle force only partially restores heart function in aged Mdx mice. Mol Therapy J Am Soc Gene Therapy 17:253 Bostick B, Yue Y, Long C, Marschalk N, Fine DM, Chen J, Duan D (2009) Cardiac expression of a mini-dystrophin that normalizes skeletal muscle force only partially restores heart function in aged Mdx mice. Mol Therapy J Am Soc Gene Therapy 17:253
Metadaten
Titel
Cardiac Phenotype–Genotype Associations in DMD/BMD: A Meta-Analysis and Systematic Review
verfasst von
Huan Zhou
Manli Fu
Bing Mao
Li Yuan
Publikationsdatum
09.10.2020
Verlag
Springer US
Erschienen in
Pediatric Cardiology / Ausgabe 1/2021
Print ISSN: 0172-0643
Elektronische ISSN: 1432-1971
DOI
https://doi.org/10.1007/s00246-020-02470-4

Weitere Artikel der Ausgabe 1/2021

Pediatric Cardiology 1/2021 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.